Differential antitumor immunity mediated by NKT cell subsets in vivo - Wikidata - wikimedia - TriplyDB

Differential antitumor immunity mediated by NKT cell subsets in vivo

Differential antitumor immunity mediated by NKT cell subsets in vivo

http://www.wikidata.org/entity/Q34603019

about

The role of NKT cells in tumor immunity How do natural killer T cells help B cells?Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell Generation The Extended Family of CD1d-Restricted NKT Cells: Sifting through a Mixed Bag of TCRs, Antigens, and Functions Fine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and function NKT cell networks in the regulation of tumor immunity The regulatory role of invariant NKT cells in tumor immunity The immunoregulatory role of type I and type II NKT cells in cancer and other diseases A semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties Immunity, Inflammation, and Cancer Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury.Toll-like receptor 3 ligand dampens liver inflammation by stimulating Valpha 14 invariant natural killer T cells to negatively regulate gammadeltaT cells.Invariant NKT Cell Activation Induces Late Preterm Birth That Is Attenuated by Rosiglitazone.Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells.Lymphocytes in cancer development: polarization towards pro-tumor immunity ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival.Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.NKG2A inhibits invariant NKT cell activation in hepatic injury.All-trans-retinoic acid and the glycolipid α-galactosylceramide combined reduce breast tumor growth and lung metastasis in a 4T1 murine breast tumor model.Fatty acid amide hydrolase shapes NKT cell responses by influencing the serum transport of lipid antigen in mice.CD1d-expressing breast cancer cells modulate NKT cell-mediated antitumor immunity in a murine model of breast cancer metastasis.The functional cancer map: a systems-level synopsis of genetic deregulation in cancer Lipid antigens in immunity.Secretion of IFN-gamma but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen.CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice Distinct and overlapping effector functions of expanded human CD4+, CD8α+ and CD4-CD8α- invariant natural killer T cells Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines Langerhans cells serve as immunoregulatory cells by activating NKT cells.Thymic and peripheral microenvironments differentially mediate development and maturation of iNKT cells by IL-15 transpresentation.Bcl-xL regulates CD1d-mediated antigen presentation to NKT cells by altering CD1d trafficking through the endocytic pathway.Antigen-specific cytotoxicity by invariant NKT cells in vivo is CD95/CD178-dependent and is correlated with antigenic potency Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infection Essential role for autophagy during invariant NKT cell development.Chronic alcohol consumption enhances iNKT cell maturation and activation

P2860

Q24648939-CA44D070-9CA5-4BBB-A446-F652E86EC45C Q24650966-9DABE465-4E46-44E2-BFAB-59CD0CBDD07E Q26748456-620E8198-7AD8-4DFC-80A6-E2F2B0934BC7 Q26768699-863BC70B-13F1-48BE-885A-A4793F9FA79B Q26797344-73CBC8F6-A974-4ED8-89F1-76404B1B315C Q26797347-0052B513-3E2E-49AD-A458-199F14C1C2BE Q26830239-92C14D0D-2500-489A-9517-2CB9963E8AC7 Q26866223-9F10CDCF-E5BA-4A6B-BB3D-F841D060A05E Q27023425-AF83D544-F383-4CAB-9847-D6DF5B7C559E Q27027556-AE6507D8-8DFA-4348-A4FE-E073F623023E Q27670418-627469CA-72C7-4338-A2C8-9B6FBB9C58DB Q27861048-BF740D40-9539-42A3-8740-E2693165D56A Q28294740-2661286D-043A-41A7-B63E-84B3C7E8C0BE Q28511526-3D3E7E30-B4AC-4549-A1D9-0910EF03DD07 Q28584907-E9D6F1FF-EA50-49F3-A825-1D5641940F40 Q30426574-AC152F06-9B90-450A-8911-93D8DEA9A0EC Q30432794-E1DE65BA-976A-4FA4-8322-060496116816 Q30700375-B85AFB06-D7CF-4C10-8CB1-C3170C0C0197 Q33267309-DF5095BD-A849-4B87-BF8C-6BCA1DA28919 Q33523809-5A7ABAB4-4531-4072-89F7-9468B6C1481D Q33712435-9B43B045-C63F-4DC4-95E1-2B72F4371030 Q33715268-510141BD-99F3-44C1-8B95-5841CFE943A1 Q33724575-37B67C5C-133A-4B59-A015-4F7C1A14DFF4 Q33739557-E6E73BE0-886B-4DC4-A845-785903D9689B Q33769503-76257BD6-8240-42B9-AE90-DE1D25658658 Q33882880-80D099EA-DAFD-47CA-A91C-508F26688581 Q33939552-D110F4EF-A3B1-4C96-95DC-7AA0CFDEB1D1 Q33947216-EB429F92-7782-4C16-A012-08362668EDC8 Q34025822-4F4F6CCC-229B-40B9-9102-64039C7C3BE3 Q34065735-E40CFDF6-AC75-46CF-AF3B-D21B18EC0B4F Q34091467-9CFB61A1-CF21-4A69-8380-4074F088DD77 Q34103244-DBF1DE13-1063-4A61-9E10-E91DF92BB3BE Q34162198-8769298C-8F59-473A-807B-EE361BAA85E4 Q34179869-665B4BC1-13EB-4A9D-8F2C-0E0F28B931F1 Q34193542-453E285E-40F7-4A15-ABD5-8F2C2034DE52 Q34216393-FB537061-FD1D-4C01-A194-B91EF5430FB7 Q34338958-CA54AC57-D87F-4087-BE8C-54940F84C6C8 Q34426479-FC91E08A-84C8-4850-9080-57482865A532 Q34831651-30E64C96-9E49-42E1-9D99-6BD676EC03CE Q34987153-58423577-20B3-4B59-B17A-8C7270D79CC2

P2860

Differential antitumor immunity mediated by NKT cell subsets in vivo

http://www.wikidata.org/entity/Q34603019

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Differential antitumor immunity mediated by NKT cell subsets in vivo

@ast

Differential antitumor immunity mediated by NKT cell subsets in vivo

@en

Differential antitumor immunity mediated by NKT cell subsets in vivo

@nl

type

label

Differential antitumor immunity mediated by NKT cell subsets in vivo

@ast

Differential antitumor immunity mediated by NKT cell subsets in vivo

@en

Differential antitumor immunity mediated by NKT cell subsets in vivo

@nl

prefLabel

Differential antitumor immunity mediated by NKT cell subsets in vivo

@ast

Differential antitumor immunity mediated by NKT cell subsets in vivo

@en

Differential antitumor immunity mediated by NKT cell subsets in vivo

@nl

P1433

Q34603019-42DA56BD-5E44-4E3E-BCDC-376BAB48EAEE

P1476

Q34603019-5A47A5D7-BAD1-46EE-8631-A2CC1DAEF144

P2093

Q34603019-374069F3-A680-4409-9C27-D940D6875F99

Q34603019-48F93994-6F75-4786-AAC9-396344E2133C

Q34603019-5053AFB5-BF8C-4FCC-A82E-D7802023A4E1

Q34603019-7D227016-50CC-4B8E-B3BF-DFBC2DACFBA1

Q34603019-CCBB8DD6-AC79-4021-9E06-BA2AFBCEA7D0

P2860

Q34603019-03BA163D-C85C-4DFC-96FD-98E2A05B3DF7

Q34603019-044BEB3C-2EAD-4674-802C-71B30B08AC95

Q34603019-0A6DACBF-F499-41A3-85B7-749D856CED7F

Q34603019-0BB1280E-152C-4328-879A-22E3F8400BB7

Q34603019-10152377-B300-40EC-9139-ABB6764BBD55

Q34603019-1A6CCB76-FF04-434C-BD93-FF7589C197C6

Q34603019-27ED62BE-8586-46C1-A4DE-AE210FD52CDC

Q34603019-2E37EA85-655B-4E20-9330-8764830AF8BC

Q34603019-338CDC2F-1ADB-4069-9EEF-A80ED294885E

Q34603019-3744338C-1298-4C93-A3BB-62BF6BFA2E1A

P304

Q34603019-051C3234-1061-4AF2-8A48-BA5DC8B492E2

P31

Q34603019-B46850D5-DCDC-4D1C-BAE2-E25241E800C6

P356

Q34603019-99B50527-DD17-4664-8A25-D10202DB5072

P407

Q34603019-9737B275-32C8-4A1A-A330-FF64F59DF5E3

P433

Q34603019-297C37C7-B335-4D4F-B690-77A56780FCB6

P478

Q34603019-CAC608D8-A55F-462F-9E2D-607C26F06D8A

P50

Q34603019-848D64A9-403A-45DF-9FC2-A4D251EA2F83

Q34603019-A453D48F-2579-4AB8-9ABA-C251D750C50D

Q34603019-D8E545A4-9451-4BE0-8F3D-8BF6AD910B3E

Q34603019-DC524BE6-FBA9-4F2E-A9AD-7FB79F899544

P577

Q34603019-A6F0664F-8671-46EE-A21D-86936656FA13

P5875

Q34603019-79ECF07E-2C3B-4761-850B-EB93E5602242

P698

Q34603019-9F7B9580-7308-4512-9F39-17B91E503657

P932

Q34603019-C34C8F39-C227-4BAD-BBEE-9AC4E7919878

P356

P1433

Journal of Experimental Medicine

P1476

Differential antitumor immunity mediated by NKT cell subsets in vivo

@en

P2093

Konstantinos Kyparissoudis

http://www.w3.org/2001/XMLSchema#string

Nadine Y Crowe

http://www.w3.org/2001/XMLSchema#string

Rachael Keating

http://www.w3.org/2001/XMLSchema#string

Stuart P Berzins

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Hayakawa

http://www.w3.org/2001/XMLSchema#string

P2860

CD1: antigen presentation and T cell function

CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4

Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells

Sea-level fingerprinting as a direct test for the source of global meltwater pulse IA.

NKT cells - conductors of tumor immunity?

Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity.

Alpha-galactosylceramide: potential immunomodulatory activity and future application.

CD1d-restricted T-cell subsets and dendritic cell function in autoimmunity.

Going both ways: immune regulation via CD1d-dependent NKT cells.

Toward an understanding of NKT cell biology: progress and paradoxes.

P304

1279-1288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20050953

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

202

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan Coquet

Daniel G Pellicci

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7492049

http://www.w3.org/2001/XMLSchema#string

P698

16275765

http://www.w3.org/2001/XMLSchema#string

P932

1459911

http://www.w3.org/2001/XMLSchema#string